Schedule 13D ownership disclosure
ATRIUM THERAPEUTICS INC
Security class unavailable · CUSIP: N71546100
Event date: 2015-01-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 96.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-029885
- Form type
- SC 13D
- Filer
- BIOMARIN PHARMACEUTICAL INC
- CIK
- CIK 1048477
- Filed
- Feb 02, 2015
- Reporting period
- Jan 29, 2015
- Description
- Schedule 13D beneficial ownership